OPRX Q4 2024 Earnings — OptimizeRx Corporation Revenue & Financial Results | Market Cap Arena

OPRXOptimizeRx Corporation

$128M

Q4 2024 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$32M+13.9% YoY

Gross Profit

$22M68.1% margin

Operating Income

$4M11.2% margin

Net Income

-$78,000-0.2% margin

EPS (Diluted)

$-0.00

QoQ Revenue Growth

+51.7%

Cash Flow

Operating Cash Flow

$198,000

Free Cash Flow

$78,000

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$171M

Total Liabilities

$54M

Stockholders' Equity

$117M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$32M	$28M	+13.9%
Gross Profit	$22M	$18M	+23.4%
Operating Income	$4M	-$11M	+133.3%
Net Income	-$78,000	-$4M	+98.1%